Day One Biopharmaceuticals (DAWN) Surges 26.7%: Is This an Indication of Further Gains?

Day One Biopharmaceuticals, Inc. (DAWN) shares rallied 26.7% in the last trading session to close at $11.33. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 6.9% gain over the past four weeks.The stock rallied after the company reported robust preliminary sales numbers for the fourth quarter and full-year 2025 related to its lead marketed drug, Ojemda. The drug is approved for treating patients aged six month ...